Literature DB >> 13959276

The inhibition of incorporation of leucine into protein of cell-free systems from rat liver and Escherichia coli by chlortetracycline.

T J FRANKLIN.   

Abstract

Entities:  

Keywords:  CHLORTETRACYCLINE; ESCHERICHIA COLI; LEUCINE; LIVER

Mesh:

Substances:

Year:  1963        PMID: 13959276      PMCID: PMC1201982          DOI: 10.1042/bj0870449

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  7 in total

1.  Amino acid transfer from aminoacyl-ribonucleic acids to protein on ribosomes of Escherichia coli.

Authors:  D NATHANS; F LIPMANN
Journal:  Proc Natl Acad Sci U S A       Date:  1961-04-15       Impact factor: 11.205

2.  Thermal conversion of nonpriming deoxyribonucleic acid to primer.

Authors:  F J BOLLUM
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

3.  Studies on incorporation of amino acids into protein in isolated rat-liver ribosomes.

Authors:  A KORNER
Journal:  Biochem J       Date:  1961-10       Impact factor: 3.857

4.  The effect of hypophysectomy of the rat and of treatment with growth hormone on the incorporation of amino acids into liver proteins in a cell-free system.

Authors:  A KORNER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

5.  A soluble ribonucleic acid intermediate in protein synthesis.

Authors:  M B HOAGLAND; M L STEPHENSON; J F SCOTT; L I HECHT; P C ZAMECNIK
Journal:  J Biol Chem       Date:  1958-03       Impact factor: 5.157

6.  The assimilation of amino-acids by bacteria. XV. Actions of antibiotics on nucleic acid and protein synthesis in Staphylococcus aureus.

Authors:  E F GALE; J P FOLKES
Journal:  Biochem J       Date:  1953-02       Impact factor: 3.857

7.  Characteristics and stabilization of DNAase-sensitive protein synthesis in E. coli extracts.

Authors:  J H MATTHAEI; M W NIRENBERG
Journal:  Proc Natl Acad Sci U S A       Date:  1961-10-15       Impact factor: 11.205

  7 in total
  22 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Biochemical studies with a new cytotoxic immunosuppressive agent, 3-acetyl-5-(4-fluorobenzylidene)-2,5-dihydro-4-hydroxy-2-oxothiophen (I.C.I. 47776).

Authors:  T J Franklin; B Higginson
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

3.  The synthesis of ribonucleic acid during inhibition of Escherichia coli by chlortetracycline.

Authors:  I A Holmes; D G Wild
Journal:  Biochem J       Date:  1965-10       Impact factor: 3.857

4.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

6.  The 'active' accumulation of tetracycline by Escherichia coli.

Authors:  T J Franklin; B Higginson
Journal:  Biochem J       Date:  1969-03       Impact factor: 3.857

7.  Effects of tetracycline on pancreatic protein synthesis and secretion in pigeons.

Authors:  P C Tucker; P D Webster
Journal:  Am J Dig Dis       Date:  1972-08

8.  The effect of chlortetracycline on the transfer of leucine and 'transfer' ribonucleic acid to rat-liver ribosomes in vitro.

Authors:  T J Franklin
Journal:  Biochem J       Date:  1964-03       Impact factor: 3.857

9.  Resistance of Escherichia coli to tetracyclines. Changes in permeability to tetracyclines in Escherichia coli bearing transferable resistance factors.

Authors:  T J Franklin
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

10.  R-factor-mediated resistance to tetracycline in Proteus mirabilis.

Authors:  T J Franklin; R Rownd
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.